Skip to main content
Home
Toggle menu

Give Now

  • For Patients
  • School Of Medicine
  • About
    • Leadership
    • Department Directory
    • News
    • Events
    • Annual Report
    • Nashville
  • Divisions
    • Allergy, Pulmonary and Critical Care Medicine
    • Cardiovascular Medicine
    • Diabetes, Endocrinology and Metabolism
    • Epidemiology
    • Gastroenterology, Hepatology and Nutrition
    • General Internal Medicine and Public Health
    • Genetic Medicine and Clinical Pharmacology
    • Geriatric Medicine
    • Hematology and Oncology
    • Infectious Diseases
    • Nephrology and Hypertension
    • Rheumatology and Immunology
  • Education
    • Overview
    • Internal Medicine Residency Program
    • Physician-Scientist Training Program
    • Internal Medicine-Pediatrics Residency Program
    • Fellowship Programs
    • EXCellence In TEaching Pathway
    • Physician-Scientist Doctoral Program
    • Medical Students
    • Alumni
    • Medicine Grand Rounds
  • Research
    • Overview
    • Clinical Trials
    • Publications
    • Research Centers and Labs
  • Faculty
    • Open Faculty Positions
    • Professional Development
  • Clinical Initiatives
    • Digital Health
    • Physician Builder Program

User Detail

Melinda Aldrich, PhD, MPH

Professor of Medicine

Division of Genetic Medicine and Clinical Pharmacology
Melinda Aldrich
Professional Bio
Melinda Aldrich, PhD, MPH, is a Professor in the Division of Genetic Medicine and Clinical Pharmacology within the Department of Medicine at Vanderbilt University Medical Center. Her research has two central area of focus: (1) understand genetic and non-genetic factors contributing to lung cancer and (2) address lung cancer screening access. Dr. Aldrich's lab collaborates with large-scale population-based cohorts such as the Southern Community Cohort Study, the Multiethnic Cohort, the Black Women's Health Study, biobanks linked to electronic health records, such as the Vanderbilt DNA biobank, BioVU, as well as international consortia such as the International Lung Cancer Consortium and LC3. The Aldrich Lab is also collaborating with national colleagues to investigate the genetics of immunotherapy treatment among lung cancer patients. Dr. Aldrich leads community-engaged dissemination strategies to build awareness around the importance of early detection of lung cancer. Her research has been used in key guidelines for lung cancer screening from the U.S. Preventive Services Task Force.
Relevant Links
Aldrich Lab VICC Profile
Publications
View Publications

Education

MPH - University of California, Berkeley, 2003

PhD - Epidemiology - University of California, Berkeley, 2007

Fellowship - Genetic Epidemiology - University of California, Berkeley, 2010

Contact

Email 
Kimryn.Rathmell@Vumc.Org 
Address 
777 Preston Research Building 
2220 Pierce Ave 
Nashville, TN 37232-6307

Submitted by admin on Thu, 06/01/2023 - 04:28

1161 21st Ave S
Nashville, TN 37232

(615) 322-5000

Quick Links

  • Home
  • About
  • Divisions
  • Education
  • Research
  • Faculty
  • Intranet

Support Our Work

Start a fundraiser or donate to the Department of Medicine.

Give Now

Vanderbilt Health is committed to fostering an environment where everyone has the chance to thrive and is committed to the principles of equal opportunity. EOE/Vets/Disabled.

Copyright © Vanderbilt University Medical Center

sfy39587stp18